Akifumi Morinaka, CEO of Rege Nephro Co., Ltd. (Headquarters: Kyoto, Japan), participated in the ‘JHVS Symposium for Medical Ventures and Academia – Global Expansion of Japanese Technological Seeds: The Future of Healthcare Startups’ held at Tokyo Midtown Yaesu Conference on February 22, 2025.

This symposium featured a diverse program, including presentations by the Ministry of Health, Labour and Welfare on industry trends and future policies for healthcare startups, pitch sessions by Japanese healthcare startups to overseas venture capitalists, and talk sessions with overseas venture capitalists. It was held with the aim of building an ecosystem and expanding networks for Japanese healthcare startups to achieve global success.

Our CEO, Morinaka gave a lecture on the progress of research and development of the lead products RN-014 and RN-032, and the future global expansion.

Leveraging the insights gained from this symposium, we will continue to advance our business to contribute to the development of Japan’s medical innovation.